目的:探讨小干扰RNA(small interference RNA,siRNA)介导的细胞色素CYP1B1(cytochrome P-450181,CYP1B1)基因沉默对二十碳五烯酸(eicosapentaenoic acid,EPA)和花生四烯酸(arachidonic acid,AA)作用下乳腺癌MDA—MB-231细胞增殖的影响。方法:应用细胞计数试剂盒(cellcountingkit一8,CCK-8)检测经EPA和从处理后MDA—MB-231细胞的增殖情况。采用RNA干扰(RNA interference,RNAi)技术干扰CYP1B1的表达,随后应用荧光实时定量PCR(real—time fluorescence quantitative PCR,RFQPCR)和蛋白免疫印迹法检测转染效率,以及siRNA干扰后EPA和从作用下MDA—MB-231细胞中CYPIBl和儿茶酚氧位甲基转移酶(catechol—O—methyltransferase,COMT)mRNA和蛋白的表达情况。采用CCK-8法检测siRNA干扰后EPA和从作用下MDA—MB-231细胞的增殖情况。结果:EPA处理组的MDA—MB-231细胞数明显少于对照组,而AA处理组的MDA—MB-231细胞则明显多于对照组(P〈0.05)。转染CYP1B1 siRNA的MDA—MB-231细胞中,CYP1B1mRNA和蛋白的表达均有所下降,而CoMTmRNA和蛋白的表达水平则有所上升。CYP1B1 siRNA转染的MDA—MB-231细胞的增殖能力下降,且EPA处理组的MDA—MB-231细胞数明显多于阴性对照组(P〈0.05)。结论:CYP1B1基因沉默能够抑制MDA—MB-231细胞的增殖,逆转EPA对细胞增殖的抑制作用。EPA可能通过调节CYP1B1的表达来抑制乳腺癌细胞的增殖。
Objective: To investigate the effect of CYP1B1 (cytochrome P-450 1B1) gene silencing induced by small interference RNA (siRNA) on the proliferation of MDA-MB-231 cells treated with EPA (eicosapentaenoic acid) and AA (arachidonic acid). Methods: The proliferation of MDA-MB-231 cells treated with EPA or AA was detected by CCK-8 (cell counting kit-8) assay. The expression of CYP1B1 was interfered by RNAi (RNA interference) technique. The transfection efficiency was examined by real- time fluorescence quantitative PCR (RFQ-PCR) and Western blotting, respectively. The expression levels of CYP1B1 and COMT (catechol-O-methyltransferase) mRNAs and proteins in MDA-MB-231 cells interfered with siRNA and treated with EPA or AA were determined by RFQ-PCR and Western blotting, respectively. The viability of breast cancer MDA-MB-231 cells interfered with siRNA and treated with EPA or AA was detected by CCK-8 assay. Results:The cell number of EPA-treated group was lower while the cell number of AA-treated group was higher than that of the control group (P〈0.05). The expression levels of CYP1B1 mRNA and protein were decreased in MDA-MB-231 cells transfected with CYP1B1 siRNA, while the expression levels of COMT mRNA and protein were increased. The proliferation of MDA-MB-231 cells transfected with CYP1B1 siRNAwas inhibited, and the number of MDA-MB-231 cells treated with EPA was significantly higher than that of the negative control group (P〈0.05). Conclusion: CYP1B1 gene silencing inhibits the proliferation of MDA-MB-231 cells and reverses the inhibitory effect of EPA on the cell proliferation. EPA probably inhibits the cell proliferation through regulating the expression of CYP1 B1 in breast cancer.